- The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back Ukraine, the Wall Street Journal reported citing administration officials.
- The White House is asking about $22.4 billion for Covid-19 vaccines, trials, and testing; $3.9 billion to fight against monkeypox; and $4.5 billion to prepare for and recover from natural disasters.
- The administration is also asking for $13.7 billion to continue supporting Ukraine.
- Last month, the White House Covid-19 Response Coordinator said the Biden administration would stop buying COVID-19 vaccines and treatments as the U.S. plans to get out of the crisis phase.
- Congress must vote on a spending bill by the end of September to avoid a partial government shutdown as the lawmakers expect to use a stopgap funding measure that will help maintain funding levels for the short term.
- Spending bills require 60 votes, and in the 50-50 Senate, at least 10 Republicans would need to back any bill that contained the administration’s request.
- In May, Congress passed a nearly $40 billion military and economic aid package to help Ukraine, and lawmakers expect further funding needs as the war continues.
- Photo via Wikimedia Commons
Loading...
Loading...
AZNAstraZeneca PLC
$68.00-3.22%
Edge Rankings
Momentum
54.35
Growth
89.16
Quality
63.61
Value
20.15
Price Trend
Short
Medium
Long
BNTXBioNTech SE
$92.00-2.89%
BVNKFBavarian Nordic AS
$23.08-%
BVNRYBavarian Nordic AS
$7.82-0.38%
EBSEmergent BioSolutions Inc
$5.3010.7%
GOVXGeovax Labs Inc
$0.9160-1.57%
GSKGSK PLC
$36.75-2.00%
JNJJohnson & Johnson
$154.800.21%
LLYEli Lilly and Co
$755.00-2.60%
MRNAModerna Inc
$23.62-3.32%
PFEPfizer Inc
$22.58-1.31%
SIGASIGA Technologies Inc
$5.25-0.38%
TNXPTonix Pharmaceuticals Holding Corp
$19.040.85%
VIRVir Biotechnology Inc
$5.41-3.91%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in